Synthesis and investigation of catalytic activity of phenylene – And biphenylene bridged bimetallic Palladium-PEPPSI complexes

Bimetallic PdII complexes with NHC/Py/PCy3 donor set ligands: applications in α-arylation, Suzuki–Miyaura and Sonogashira coupling reactions

Bimetallic PdII complexes bearing mixed NHC/Py/PCy3 donor set ligands are presented. A complex with a mixed NHC/PCy3 donor set ligands shows superior activity compared to the PEPPSI type complexes in α-arylation and Sonogashira coupling reactions.

Nickel catalysts in Sonogashira coupling reactions

Nickel has emerged as a desirable substitute for palladium in Sonogashira coupling reactions due to its abundance, less toxicity and high catalytic activity. Ni complexes have been developed to catalyse C(sp)-C(sp²) and C(sp)-C(sp³) Sonogashira couplings that find applications in the synthesis and modifications of biologically relevant molecules. This review focuses on the catalytic potential and mechanistic details of various Ni complexes employed in the Sonogashira coupling. These include homogeneous catalytic systems with Ni-phosphorus and Ni-nitrogen catalysts, ligand-free catalysts, and carbonylative coupling strategies. Various heterogeneous catalytic systems using supported Ni complexes, Ni nanoparticles and Pd-Ni bimetallic catalysts have also been discussed. This is the first review reported so far dealing exclusively with Ni-catalysed Sonogashira coupling reactions. This review illustrates the current strategies and potential of Ni-catalysed Sonogashira coupling reactions in both homogeneous and heterogeneous systems, and covers the literature up to 2020.

Copper-free Sonogashira cross-coupling reactions: an overview

The Sonogashira reaction is a cross-coupling reaction of a vinyl or aryl halide with a terminal alkyne to form a C-C bond. In its original form, the Sonogashira reaction is performed with a palladium species as a catalyst while co-catalyzed by a copper species and a phosphine or amine. The reaction is conducted under mild conditions, i.e., room temperature, aqueous solutions, and the presence of mild bases. Undeniably, the Sonogashira reaction is among the most competent and efficient reactions widely used in organic synthesis. This named reaction has proved useful in many organic synthesis areas, including the synthesis of pharmaceuticals, heterocycles, natural products, organic compounds, complex molecules having biological activities, nanomaterials, and many more materials that we use in our daily lives. The presence of transition metals as a catalyst was indeed essential in the Sonogashira reaction. However, recently, the reaction has been successfully conducted without copper as a co-catalyst and phosphines or amines as bases. In this critical review, we have focused on developments in the Sonogashira reaction successfully performed in the absence of copper complexes, phosphines or amines, which could be of particular advantage in implementing green chemistry principles and making the reactions more achievable from an economic viewpoint.

Recent advances in NHC–palladium catalysis for alkyne chemistry: versatile synthesis and applications

This review summarizes the recent developments in NHC–palladium catalysis for alkyne chemistry: versatile synthesis and applications.

Pd-N-heterocyclic carbene complex catalysed C–H bond activation of 2-isobutylthiazole at the C5 position with aryl bromides

An effective and efficient catalytic system has been reported for the synthesis of C5-arylated 2-isobutylthiazoles.

Biological Activities of NHC–Pd(II) Complexes Based on Benzimidazolylidene N-heterocyclic Carbene (NHC) Ligands Bearing Aryl Substituents

N-heterocyclic carbene (NHC) precursors (2a–i), their pyridine-enhanced precatalyst preparation stabilization and initiation (PEPPSI)-themed palladium N-heterocyclic carbene complexes (3a–i) and palladium N-heterocyclic triphenylphosphines complexes (4a–i) were synthesized and characterized by elemental analysis and 1H NMR, 13C NMR, IR, and LC–MS spectroscopic techniques. The (NHC)Pd(II) complexes 3–4 were tested against MCF7 and MDA-MB-231 cancer cells, Escherichia coli, methicillin-resistant Staphylococcus aureus (MRSA), Candida albicans microorganisms, Leishmania major promastigotes and amastigotes, Toxoplasma gondii parasites, and Vero cells in vitro. The biological assays indicated that all compounds are highly active against cancer cells, with an IC50 < 1.5 µg mL−1. Eight compounds proved antibacterial and antileishmanial activities, while only three compounds had strong antifungal activities against C. albicans. In our conclusion, compounds 3 (b, f, g, and h) and 4b are the most suitable drug candidates for anticancer, antimicrobial, and antiparasitical.